Institute for Integration of Medicine & Science: A Partnership to Improve Health
医学整合研究所
基本信息
- 批准号:10487947
- 负责人:
- 金额:$ 1.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-28 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AreaCitiesClinical ResearchClinical SciencesClinical TrialsCommunitiesComplexCountyDevelopmentDiabetes MellitusDoctor of PhilosophyEffectivenessElectronic Health RecordFosteringGrantHealthHealth InsuranceHealth SciencesHealth Services AccessibilityHealthcare SystemsHispanic PopulationsHomeInformaticsInstitutesInstitutionInstitutional Review BoardsInvestmentsKnowledgeLearningMalignant NeoplasmsMaster&aposs DegreeMedicalMedicineMethodsMilitary PersonnelMinorityObesityPathway interactionsPopulationPopulation HeterogeneityPositioning AttributePovertyProcessProgram DevelopmentResearchResearch PersonnelResearch PriorityResourcesRuralRural PopulationScienceServicesSouth TexasStudentsTNFSF15 geneTimeTrainingTranslatingTranslational ResearchVeteransVisionWorkforce Developmentactive dutybiomedical scientistcare deliverycare outcomescostdata warehousedisparity reductionhealth disparityimprovedinnovationmetropolitanmilitary veteranpractice-based research networkprogramsservice membersuccesstranslational scientist
项目摘要
Overall-Abstract
San Antonio, positioned at the gateway to South Texas, is the 7th largest US city and the
largest metropolitan area with a minority-majority population. Our 38-county region comprises an impoverished,
rural, and largely Hispanic population with disproportionate rates of diabetes, obesity, and cancer, exacerbated
by lack of health insurance and poor access to care. The region is home to major US military facilities, including
the world’s largest military medical complex. Service members and veterans form populations with special needs.
Neither better access to care nor improved care delivery, on their own, can eliminate health disparities. Innovative
translational research is required to fill knowledge gaps and establish real-world effectiveness to improve health.
In 2006, UT Health Science Center-San Antonio established the Institute for Integration of Medicine &
Science (IIMS) as the academic home for our growing translational science initiatives, training the translational
science workforce, formalizing key strategic partnerships, and creating a community of scholars within a learning
healthcare system. We expanded clinical research programs, dramatically increasing access to clinical trials.
We developed 6 Practice-Based Research Networks that focus on diverse ambulatory populations. We created
6 county-wide Translational Advisory Boards that support engagement through priority setting and matching with
academic investigators. IIMS pioneered IRB process harmonization, resulting in rapid review times and
streamlined pathways to multisite study initiation. We operate a robust pilot grant program, leveraged among our
partners, with a remarkable return on investment. Our workforce development programs, with matriculants
reflecting our diverse population, have graduated 133 masters degree students, supported 27 successful KL2
Scholars and 16 TL1 Scholars, and established de novo a Translational Science PhD program. Our informatics
team has led electronic health record data warehouse development, fostering matches between IIMS
investigators and practice-relevant research priorities. IIMS is now poised to deploy our robust portfolio of
programs across our growing, leveraged, and innovative network of institutional and community partners.
In this proposal, we provide clear strategies to support clinical and translational science across partner
organizations, catalyze research team success, and implement programs that produce creative, collaborative,
and culturally diverse translational scientists. IIMS seeks exceptionalism in translating scientific discoveries
across the T1 to T4 spectrum into improved health care outcomes. Our over-arching Specific Aims are:
1. Accelerate clinical and translational research innovation and team science along the entire T1 to T4
research spectrum by providing an academic home integrated with our strategic partner institutions
2. Expand, diversify, and enhance the workforce of interdisciplinary translational biomedical scientists
3. Implement effective methods to continuously evaluate and optimize services, increase efficiencies,
improve processes, endorse common metrics, and reduce costs across all IIMS programs
总体提取
圣安东尼奥(San Antonio)位于通往德克萨斯州南部的门户,是美国第七大城市,
最大的大都市地区,有少数群体人口。我们的38个县区包括一个贫穷的,
糖尿病,肥胖和癌症发生不成比例的西班牙裔人口大致,加剧了
由于缺乏健康保险和无法获得护理的机会。该地区是美国主要军事设施的所在地,包括
世界上最大的军事医疗综合体。服务成员和退伍军人组成有特殊需要的人群。
没有更好地获得护理的机会,也不能自行改善护理服务,无法消除健康差异。创新的
需要翻译研究以填补知识空白并建立现实世界的有效性以改善健康。
2006年,UT健康科学中心安东尼奥建立了医学整合研究所
科学(IIMS)是我们不断发展的转化科学计划的学术家园,培训翻译
科学劳动力,格式化关键战略伙伴关系,并在学习中建立学者社区
医疗保健系统。我们扩大了临床研究计划,大大增加了对临床试验的访问。
我们开发了6个基于实践的研究网络,这些研究网络专注于潜水员的门诊人群。我们创建了
6县范围范围的翻译咨询委员会,通过优先设置并与
学术研究人员。 IIMS开创了IRB流程的协调,导致了快速的审查时间和
流线型多站点研究计划的途径。我们运营着一个强大的试点赠款计划,在我们的
合作伙伴,具有惊人的投资回报。我们的劳动力开发计划,包括母亲
反映我们的潜水员人口,已经毕业了133位硕士学位学生,并支持27个成功的KL2
学者和16个TL1学者,并建立了从头转化科学博士学位课程。我们的信息
团队领导了电子健康记录数据仓库开发,促进了IIM之间的比赛
研究人员和实践研究重点。 IIMS现在被中毒以部署我们强大的投资组合
我们成长,杠杆和创新的机构和社区合作伙伴网络的计划。
在此提案中,我们提供了明确的策略,以支持合作伙伴的临床和翻译科学
组织,催化研究团队的成功并实施产生创造性,协作的计划,
和文化多样的转化科学家。 IIM在翻译科学发现时寻求例外主义
跨T1到T4频谱改善了医疗保健结果。我们整理的具体目的是:
1。加速临床和翻译研究创新和团队科学沿整个T1到T4
通过提供与我们的战略合作伙伴机构整合的学术房屋来提供的研究范围
2。扩展,多样化和增强跨学科转化生物医学科学家的劳动力
3.实施有效方法来连续评估和优化服务,提高效率,
改善流程,认可通用指标并降低所有IIM计划的成本
项目成果
期刊论文数量(55)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Social Support and the Rehabilitation of Alcohol-Impaired Drivers: Drinking Motives as Moderators.
社会支持和酒后驾车者的康复:饮酒动机作为调节者。
- DOI:10.1080/10410236.2020.1731914
- 发表时间:2021
- 期刊:
- 影响因子:3.9
- 作者:Moon,Tae-Joon;Mathias,CharlesW;Mullen,Jillian;Karns-Wright,TaraE;Hill-Kapturczak,Nathalie;Roache,JohnD;Dougherty,DonaldM
- 通讯作者:Dougherty,DonaldM
Development of a Mobile Application to Enhance Knowledge, Awareness and Communication of Dry Mouth Amongst Dental Practitioners and Patients: A South Texas Oral Health Network Study.
开发移动应用程序以增强牙科医生和患者对口干症的知识、意识和沟通:南德克萨斯州口腔健康网络研究。
- DOI:
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Mungia,Rahma;Mendoza,Marissa;delaRosa,Elisabeth;Nguyen,Thi;Reyes,StephanieC;Schramm,Danielle;Taverna,Melanie
- 通讯作者:Taverna,Melanie
Health Equity in Patients Receiving Durvalumab for Unresectable Stage III Non-Small Cell Lung Cancer in the US Veterans Health Administration.
- DOI:10.1093/oncolo/oyad172
- 发表时间:2023-09-07
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Further evidence supporting a potential role for ADH1B in obesity.
- DOI:10.1038/s41598-020-80563-z
- 发表时间:2021-01-21
- 期刊:
- 影响因子:4.6
- 作者:Morales LD;Cromack DT;Tripathy D;Fourcaudot M;Kumar S;Curran JE;Carless M;Göring HHH;Hu SL;Lopez-Alvarenga JC;Garske KM;Pajukanta P;Small KS;Glastonbury CA;Das SK;Langefeld C;Hanson RL;Hsueh WC;Norton L;Arya R;Mummidi S;Blangero J;DeFronzo RA;Duggirala R;Jenkinson CP
- 通讯作者:Jenkinson CP
Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation.
- DOI:10.1016/j.psyneuen.2018.04.019
- 发表时间:2018-08
- 期刊:
- 影响因子:3.7
- 作者:Garrison AM;Parrott JM;Tuñon A;Delgado J;Redus L;O'Connor JC
- 通讯作者:O'Connor JC
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT A CLARK其他文献
ROBERT A CLARK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT A CLARK', 18)}}的其他基金
Institute for Integration of Medicine & Science: A Partnership to Improve Health
医学整合研究所
- 批准号:
10704865 - 财政年份:2023
- 资助金额:
$ 1.74万 - 项目类别:
Development of Sustainable Reporting to the National COVID Cohort Collaborative (N3C)
为国家新冠肺炎队列协作组织 (N3C) 制定可持续报告
- 批准号:
10244205 - 财政年份:2020
- 资助金额:
$ 1.74万 - 项目类别:
Institute for Integration of Medicine & Science: A Partnership to Improve Health
医学整合研究所
- 批准号:
10404497 - 财政年份:2018
- 资助金额:
$ 1.74万 - 项目类别:
Analysis of Olfactory Dysfunction for Early Diagnosis of Parkinson's Disease
嗅觉障碍对帕金森病早期诊断的分析
- 批准号:
10408715 - 财政年份:2016
- 资助金额:
$ 1.74万 - 项目类别:
Analysis of Olfactory Dysfunction for Early Diagnosis of Parkinson's Disease
嗅觉障碍对帕金森病早期诊断的分析
- 批准号:
10254880 - 财政年份:2016
- 资助金额:
$ 1.74万 - 项目类别:
Analysis of Olfactory Dysfunction for Early Diagnosis of Parkinson's Disease
嗅觉障碍对帕金森病早期诊断的分析
- 批准号:
9137152 - 财政年份:2016
- 资助金额:
$ 1.74万 - 项目类别:
Institute for Integration of Medicine & Science: A Partnership to Improve Health
医学整合研究所
- 批准号:
8877665 - 财政年份:2013
- 资助金额:
$ 1.74万 - 项目类别:
相似国自然基金
智慧城市导向下基于街景视觉表征的“人-环境”数字互联机制
- 批准号:52308015
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向城市高异质性地表的植被碳汇遥感估算研究
- 批准号:42371322
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
近代东北南满铁路沿线工业城市的建设和技术传播
- 批准号:52378030
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
大气生物源有机硝酸酯的合成、定量和其在中国南方城市的成因研究
- 批准号:22306059
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
城市污水厂生物除臭系统生物膜微界面微生物逸散行为及机制
- 批准号:52370026
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
The Role of Glycosyl Ceramides in Heart Failure and Recovery
糖基神经酰胺在心力衰竭和恢复中的作用
- 批准号:
10644874 - 财政年份:2023
- 资助金额:
$ 1.74万 - 项目类别:
Genetic and Environmental Influences on Individual Sweet Preference Across Ancestry Groups in the U.S.
遗传和环境对美国不同血统群体个体甜味偏好的影响
- 批准号:
10709381 - 财政年份:2023
- 资助金额:
$ 1.74万 - 项目类别:
International Conference on Cancer Health Disparities
国际癌症健康差异会议
- 批准号:
10606212 - 财政年份:2023
- 资助金额:
$ 1.74万 - 项目类别:
Heat therapy for the treatment of SCI-induced changes in nociceptor and mitochondrial function
热疗法治疗 SCI 引起的伤害感受器和线粒体功能变化
- 批准号:
10641385 - 财政年份:2023
- 资助金额:
$ 1.74万 - 项目类别: